Option Care Health (NASDAQ:OPCH) Updates FY25 Earnings Guidance

Option Care Health (NASDAQ:OPCH) updated its FY25 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $1.59-1.69 for the period, compared to the consensus estimate of $1.32. The company issued revenue guidance of $5.2-5.4 billion, compared to the consensus revenue estimate of $5.24 billion. Option Care Health also updated its FY 2024 guidance to 1.550-1.590 EPS.

Analyst Upgrades and Downgrades

OPCH has been the topic of several research analyst reports. Jefferies Financial Group cut Option Care Health from a “buy” rating to a “hold” rating and dropped their price objective for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. JMP Securities restated a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. UBS Group initiated coverage on shares of Option Care Health in a research report on Thursday, December 5th. They set a “neutral” rating and a $26.00 target price on the stock. Finally, Barrington Research increased their price objective on shares of Option Care Health from $32.00 to $33.00 and gave the company an “outperform” rating in a research note on Tuesday. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $29.86.

Option Care Health Price Performance

NASDAQ OPCH opened at $28.72 on Wednesday. The firm’s fifty day simple moving average is $23.33 and its two-hundred day simple moving average is $27.70. The firm has a market capitalization of $4.89 billion, a P/E ratio of 24.13, a P/E/G ratio of 2.43 and a beta of 1.31. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health has a 12-month low of $21.39 and a 12-month high of $34.63.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction on Friday, November 8th. The stock was bought at an average price of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now owns 326,334 shares in the company, valued at $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.